Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

BMJ

Volumn 323, Issue 7303, 2001, Pages 13-

  Campbell, Fiona A ^a   Tramèr, Martin R ^b   Carroll, Dawn ^c   Reynolds, D John M ^d   Moore, r Andrew ^c   Mcquay, Henry J ^c  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPYRAN DERIVATIVE; CANNABINOID DERIVATIVE; CODEINE; DRONABINOL; LEVONANTRADOL;

ANALGESIA; ARTICLE; CANCER PAIN; CENTRAL NERVOUS SYSTEM DEPRESSION; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANALGESICS, NON-NARCOTIC; CANNABINOIDS; CHRONIC DISEASE; HUMANS; NEOPLASMS; PAIN; RANDOMIZED CONTROLLED TRIALS;

EID: 0035822343     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7303.13     Document Type: Article

References (29)

1. Martin WJ, Loo CM, Basbaum AI. Cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 1999; 82(2):199–205.
2. Martin WJ. Basic mechanisms of cannabinoid-induced analgesia. IASP Newsletter 1999: 3–6.
3. Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999; 83: 637–649.
4. BM Association. Therapeutic uses of cannabis. Amsterdam: Harwood Academic, 1997.
5. Meek C. Doctors want cannabis prescriptions allowed. BMA News Review 1994: 1–19.
6. Tramèr MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy-induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323: 16–21.
7. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996; 66: 239–246.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1):1–12.
9. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Lancet 1999; 354: 1896–1900.
10. Clark WC, Janal MN, Zeidenberg P, Nahas GG. Effects of moderate and high doses of marihuana on thermal pain: a sensory decision theory analysis. J Clin Pharmacol 1981; 21(suppl 8–9):S299–S310.
11. Hill SY, Schwin R, Goodwin DW, Powell BJ. Marihuana and pain. J Pharmacol Exp Ther 1974; 188: 415–418.
12. Petro DJ, Ellenberger C Jr. Treatment of human spasticity with delta 9-tetrahydrocannabinol. J Clin Pharmacol 1981; 21(suppl 8–9):S413–S416.
13. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med 1974; 291: 65–67.
14. Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse 1987; 7(1):39–50.
15. Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, et al. Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem Behav 1991; 40: 701–708.
16. Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharmacol Ther 1994; 55: 324–328.
17. Raft D, Gregg J, Ghia J, Harris L. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. Clin Pharmacol Ther 1977; 21(1):26–33.
18. Milstein SL, MacCannell K, Karr G, Clark S. Marijuana-produced changes in pain tolerance. Experienced and non-experienced subjects. Int Pharmacopsychiatry 1975; 10: 177–182.
19. Martyn CN, Illis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet 1995; 345: 579.
20. Kantor TG, Hopper M. A study of levonantradol, a cannabinol derivative, for analgesia in post operative pain. Pain 1981; (suppl): S37.
21. Jochimsen PR, Lawton RL, VerSteeg K, Noyes R Jr. Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin Pharmacol Ther 1978; 24: 223–227.
22. Noyes R Jr, Brunk SF, Baram DA, Canter A. Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol 1975; 15: 139–143.
23. Noyes R Jr, Brunk SF, Avery DAH, Canter AC. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 1975; 18(1):84–89.
24. Staquet M, Gantt C, Machin D. Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 1978; 23: 397–401.
25. Holdcroft A, Smith M, Jacklin A, Hodgson H, Smith B, Newton M, et al. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 1997; 52: 483–486.
26. Maurer M, Henn V, Dittrich A, Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci 1990; 240(1):1–4.
27. Jain AK, Ryan JR, McMahon FG, Smith G. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol 1981; 21(suppl 8–9):S320–S326.
28. McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
29. Moertel CG, Ahmann DL, Taylor WF, Schwartau N. Relief of pain by oral medications. A controlled evaluation of analgesic combinations. JAMA 1974; 229: 55–59.